InterCure to Participate in the Cowen 3rd Annual European Cannabis Conference
15 Mai 2023 - 11:59PM
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba
Canndoc)("InterCure") today announced that Alexander Rabinovitch,
CEO of InterCure, will participate in the Cowen 3rd Annual European
Cannabis Conference, taking place May 16th, 2023 in Berlin,
Germany.
Mr. Rabinovitch will take part in the European
Frontier Markets & Israel panel on May 16th, 2023 at 10:35
AM CEST, and will be available for 1 on 1 sessions by appointment
only.
About InterCure (dba
Canndoc)
InterCure (dba Canndoc) (NASDAQ: INCR) (TSX:
INCR.U) (TASE: INCR) is the leading, profitable, and fastest
growing cannabis company outside of North America. Canndoc, a
wholly owned subsidiary of InterCure, is Israel’s largest licensed
cannabis producer and one of the first to offer Good Manufacturing
Practices (GMP) certified and pharmaceutical-grade medical cannabis
products. InterCure leverages its market leading distribution
network, best in class international partnerships and a high-margin
vertically integrated "seed-to-sale" model to lead the fastest
growing cannabis global market outside of North America.
For more information, visit:
http://www.intercure.co.
Contact:
InterCure Ltd.Amos Cohen, Chief Financial
Officeramos@intercure.co
Intercure (TSX:INCR.U)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Intercure (TSX:INCR.U)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024